-
Scientists should bolster defense against COVID-19 strains, senior biomedical engineer says
2021-03-08
The country's scientific community should continue its rigorous and intensive research on COVID-19, and bolster the nation's preparedness by developing vaccines and diagnostic kits against mutated strains of SARS-CoV-2, a senior biomedical engineer said during the second plenary meeting of the fourth session of the 13th National Committee of the Chinese People's Political Consultative Conference on March 7.
-
NMPA approves 3 TCM drugs for pulmonary disease
2021-03-06
On March 2, the NMPA granted market approval through special procedures of three traditional Chinese medicine (TCM) drugs -- Lung Cleansing and Detoxifying granules, Dampness Resolving and Detoxifying granules and Lung Diffusing and Detoxifying granules.
-
Chinese mainland reports no new locally transmitted COVID-19 cases
2021-03-05
The Chinese mainland reported no new locally transmitted COVID-19 cases on March 4, the National Health Commission said Friday.
-
Sinopharm chairman says vaccines can protect against COVID variants
2021-03-05
Early research shows that the inactivated COVID-19 vaccines produced by Sinopharm can provide protection against 10 mutated variants of SARS-CoV-2, including strains from the United Kingdom and South Africa, said Yu Qingming, Sinopharm's board chairman and a deputy to the National People's Congress.
-
Chinese mainland reports no new locally transmitted COVID-19 cases
2021-03-04
The Chinese mainland reported no new locally transmitted COVID-19 cases on Wednesday, the National Health Commission said on March 4.
-
Output of Sinopharm COVID-19 vaccines to top 1 bln doses in 2021
2021-03-04
China has put the inactivated COVID-19 vaccines developed by state-owned pharmaceutical firm Sinopharm into mass production and this year's output is expected to surpass 1 billion doses, Yu Qingming, chairman of Sinopharm Group, said on March 3.
